22:54 , Jan 31, 2017 |  BC Innovations  |  Distillery Therapeutics

Ophthalmic disease

INDICATION: Choroidal neovascularization (CNV); retinal detachment In vitro and mouse studies suggest the COL4A5-mimetic peptide AXT107 could help treat CNV and retinal detachment. In vitro, AXT107 bound integrins αvβ3 and α5β1 with Ki values of 1.29...